[IMP dehydrogenase].
Yamaoka
Takashi
T
Division of Genetic Information, Institute for Genome Research, University of Tokushima.
D000818:Animals; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D025461:Feedback, Physiological; D005799:Genes, Dominant; D006157:Guanosine Monophosphate / Q000502:physiology; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid / Q000031:analogs & derivatives; D010857:Pigment Epithelium of Eye / Q000473:pathology; D011487:Protein Conformation; D017434:Protein Structure, Tertiary / Q000235:genetics; D011685:Purine Nucleotides / Q000096:biosynthesis*; D012162:Retinal Degeneration / Q000209:etiology; D012254:Ribavirin / Q000031:analogs & derivatives; D012263:Ribonucleosides
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D011685:Purine Nucleotides; D012263:Ribonucleosides; D012254:Ribavirin; C010052:mizoribine; D006157:Guanosine Monophosphate; D007168:IMP Dehydrogenase; D009173:Mycophenolic Acid; C033706:tiazofurin